Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Vector Purification Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Viral Vector, Type of Purification Technique, Type of ...

After an investigation in an adverse event, Bluebird Bio announced that it is “very unlikely” that the BB305 lentiviral vector (LVV) caused the case of acute myeloid leukemia (AML) which was reported ...

CDMO Andelyn Biosciences says that it has manufactured a viral vector with its AAV Curator ® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program. The Adeno ...

QHP Capital (“QHP”) today announced an investment in Vector Clinical Trials (“Vector” or the “Company”), a leading clinical research site network led by Founder Dr. Bobby Mocherla. The partnership is ...

The new case of myelodysplastic syndrome (MDS) that overshadowed Bluebird Bio Inc.’s earnings and resulted in a clinical hold by the FDA will be addressed similarly to an earlier hitch in the sickle ...

Gene therapy has provided treatment options for diseases that are beyond the reach of traditional approaches. Since 2016, between the European Medicines Agency (EMA) and the U.S. Food and Drug ...

RALEIGH, N.C. & LAS VEGAS, September 30, 2025--(BUSINESS WIRE)--QHP Capital ("QHP") today announced an investment in Vector Clinical Trials ("Vector" or the "Company"), a leading clinical research ...